CD163 as a Novel Predictive Biomarker for Classical Hodgkin’s Lymphoma in patient from Saudi Arabia

The overexpression of the CD163 irritant by tumor-befriended macrophages (TAMs) in the Hodgkin’s lymphoma (HL) is considered to be a meaningful predictive biomarker for risk layer. This is most likely on account of a single nucleotide polymorphism (SNP) at the deoxyribonucleic acid promoter. The aim of this backward-looking case control study was to create a…
Read more

February 16, 2023 0